Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.

Reset all filters
01 1Baxter Ag
02 6Baxter Holding B.V.
03 3Baxter Holding Bv
04 4ACCORD HEALTHCARE LIMITED
05 3AUROBINDO PHARMA ITALIA Srl
06 7Accord Healthcare Ag
07 1Accord Healthcare B.V.
08 4Accord Healthcare BV
09 2Accord Healthcare Bv
10 5Accord Healthcare Polska Sp. Z O.O.
11 1Accord Healthcare S.L.
12 2Accord Healthcare SLU
13 4Accord Healthcare Slu
14 2Actavis Group PTC ehf
15 1Actavis Group Ptc Ehf.
16 1BLUEPHARMA - INDUSTRIA FARMACEUTICA, S.A
17 3Baxter Holding BV
18 1Central Procurement & Supplies Unit
19 1Cephalon Europe
20 1Cheplapharm Arzneimittel GmbH
21 3Cheplapharm Arzneimittel Gmbh
22 1Copharma Aps
23 1Deva Holding AS
24 3EBEWE Pharma Ges.mbH Nfg. KG
25 1Ebewe Pharma Ges.M.B.H. Nfg. Kg
26 1Ebewe Pharma Ges.M.B.H.Nfg.Kg
27 1Eugia Pharma (Malta) Limited
28 1JANSSEN CILAG INTERNAT.N.V.
29 1JV Healthcare Limited
30 1Meiji Pharma Spain Sa
31 2Mylan Hospital As
32 2Mylan S.A.S.
33 5PFIZER ITALIA Srl
34 2Pfizer AS
35 5Pfizer Ag
36 1Pfizer Aps
37 2Pfizer Sl
38 1Powercliff Limited
39 1Prohealth Limited
40 1SANDOZ SpA
41 3SEACROSS PHARMACEUTICALS
42 4Sandoz Pharmaceuticals Ag
43 1Sandoz Pharmaceuticals D.D.
44 1Sanoswiss Uab
45 1Stada Pharmaceuticals Ag
46 1TEVA B.V.
47 2TEVA ITALIA Srl
48 1Teva Bv
49 4Teva Pharma Ag
50 1Teva Pharma Bv
51 1Teva Sweden Ab
Reset all filters
01 36Doxorubicin
02 58Doxorubicin Hydrochloride
03 15Doxorubicin hydrochloride
Reset all filters
01 4Concentrate For Dispersion For Infusion
02 4Concentrate For Infusion Solution
03 43Concentrate For Solution For Infusion
04 1Doxorubicin 100Mg 50Ml 1 Units Parenteral Use
05 6Doxorubicin 10Mg 5Ml 1 Units Parenteral Use
06 3Doxorubicin 200Mg 100Ml 1 Units Parenteral Use
07 1Doxorubicin 20Mg 10Ml 1 Units Parenteral Use
08 1Doxorubicin 50Mg 1 Unit Parenteral Use
09 1Doxorubicin 50Mg 2 Units Parenteral Use
10 4Doxorubicin 50Mg 25Ml 1 Units Parenteral Use
11 1Infusion Dispersion
12 4Injectable Solution
13 1Injectable; Injection
14 1Injection Solution
15 1Liposome Injection
16 1Powder Dispersion And Solvent For Concentrate For Dispersion For Infusion
17 1Powder For Concentrate For Infusion Solution
18 3Powder For Concentrate For Solution For Infusion
19 1Powder For Dispersion Concentrate For Infusion
20 1Powder For Injectable Solution
21 4Powder For Solution For Injection
22 3SOLUTION
23 1Solution For Infusion
24 18Solution For Injection
Reset all filters
01 8Denmark
02 7Estonia
03 17Italy
04 7Malta
05 6Moldova
06 15Norway
07 1Portugal
08 9Spain
09 14Sweden
10 21Switzerland
11 1Turkey
12 3United Kingdom
Reset all filters
01 4Adriamycin
02 2Adriblastin RD
03 3Adriblastin Solution
04 5Adriblastina
05 2Caelyx
06 5Caelyx Pegylated Liposomal
07 4Caelyx pegylated liposomal
08 3Celdoxome Pegylated Liposomal
09 11Doxorubicin
10 11Doxorubicin Accord
11 1Doxorubicin Accord 2 Mg/Ml
12 2Doxorubicin Accord liposomal
13 3Doxorubicin Actavis
14 1Doxorubicin Aurovitas
15 1Doxorubicin Copharma
16 4Doxorubicin Ebewe
17 1Doxorubicin Ebewe""
18 2Doxorubicin Mylan
19 1Doxorubicin Mylan Concentrate For Soln For Inf
20 1Doxorubicin Mylan Pdr/Conc/Soln For Infus
21 4Doxorubicin Sandoz eco
22 1Doxorubicin Sanoswiss
23 1Doxorubicin Stada
24 3Doxorubicin Teva
25 1Doxorubicin "Accord"
26 1Doxorubicin "Ebewe"
27 1Doxorubicin "Teva"
28 4Doxorubicin-Teva
29 5Doxorubicin? Accord 2 mg/ml
30 1Doxorubicina Tedec
31 2Farmiblastina
32 2Myocet
33 3Myocet Liposomal
34 1Myocet liposomal
35 1Ribodoxo
36 1Zolsketil
37 3Zolsketil Pegylated Liposomal
38 2Zolsketil pegylated liposomal
39 5Blank
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Caelyx
Dosage Form : Concentrate For Solution For Infusion
Dosage Strength : 2mg/ml
Packaging :
Approval Date : 24/12/1997
Application Number : 54273
Regulatory Info : Allowed
Registration Country : Switzerland
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Regulatory Info : Prescription
Registration Country : Estonia
Brand Name : Caelyx Pegylated Liposomal
Dosage Form : Concentrate For Solution For Infusion
Dosage Strength : 2mg/ml
Packaging :
Approval Date :
Application Number :
Regulatory Info : Prescription
Registration Country : Estonia
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Regulatory Info : Prescription
Registration Country : Estonia
Brand Name : Celdoxome Pegylated Liposomal
Dosage Form : Concentrate For Dispersion For Infusion
Dosage Strength : 2mg/ml
Packaging :
Approval Date :
Application Number :
Regulatory Info : Prescription
Registration Country : Estonia
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Caelyx Pegylated Liposomal
Dosage Form : Concentrate For Infusion Solution
Dosage Strength : 2MG
Packaging :
Approval Date : 01-07-1997
Application Number : 96011001
Regulatory Info : Authorized
Registration Country : Spain
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Regulatory Info : Cancelled
Registration Country : Spain
Brand Name : Caelyx Pegylated Liposomal
Dosage Form : Concentrate For Infusion Solution
Dosage Strength : 2MG
Packaging :
Approval Date : 17-01-2001
Application Number : 96011003
Regulatory Info : Cancelled
Registration Country : Spain
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Regulatory Info : Prescription
Registration Country : Denmark
Brand Name : Caelyx Pegylated Liposomal
Dosage Form : Concentrate For Solution For Infusion
Dosage Strength : 2mg/ml
Packaging :
Approval Date : 21-06-1996
Application Number : 28101716794
Regulatory Info : Prescription
Registration Country : Denmark
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Regulatory Info : Prescription
Registration Country : Denmark
Brand Name : Celdoxome Pegylated Liposomal
Dosage Form : Concentrate For Solution For Infusion
Dosage Strength : 2mg/ml
Packaging :
Approval Date : 15-09-2022
Application Number : 28106391520
Regulatory Info : Prescription
Registration Country : Denmark
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Caelyx Pegylated Liposomal
Dosage Form : Concentrate For Solution For Infusion
Dosage Strength : 2mg/ml
Packaging :
Approval Date : 21-06-1996
Application Number : 2.00E+13
Regulatory Info : Approved
Registration Country : Sweden
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Celdoxome Pegylated Liposomal
Dosage Form : Concentrate For Solution For Infusion
Dosage Strength : 2mg/ml
Packaging :
Approval Date : 15-09-2022
Application Number : 2.02E+13
Regulatory Info : Approved
Registration Country : Sweden
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Doxorubicin Accord
Dosage Form : Solution For Injection
Dosage Strength : 10mg/5ml
Packaging :
Approval Date : 14/07/2022
Application Number : 68746
Regulatory Info : Allowed
Registration Country : Switzerland
